secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001606498-23-000052
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical agrees to acquire Diros Technology, RF pain management portfolio strengthened
--------------------------------------------------------------------------------

- Deal includes all outstanding shares of Diros Technology; financial terms not disclosed.
- Financed via existing credit facility and available cash; expected to close Q3 2023.
- Diros is a Toronto-based manufacturer of radiofrequency ablation products for chronic pain.
- Avanos expects the acquisition to be immediately accretive to revenue, gross margins, operating margins, and EPS.
- Diros' RF Trident technology complements Avanos' existing COOLIEF Cooled Radiofrequency product line.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000052/0001606498-23-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000052/avns-20230619.htm
  HTML page:      https://secwatch.observer/filing/0001606498-23-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer